GLP-1 RAs are not linked to an increased risk for serious GI or hepatobiliary outcomes, compared with other diabetes medications.

COVID-19 infection increases the risk for respiratory type-2 inflammatory disease and vaccination reduces the risk.

Unfavorable patterns of change in cardiovascular health during young adulthood tied to marked elevations in risk for later cardiovascular disease. HealthDay News — Cardiovascular health (CVH) in young ...

Universal free school meal policies, such as the Community Eligibility Provision, may be associated with improved blood pressure in students.

The approval was based on the SOUL trial, which evaluated oral semaglutide in adults 50 years and older with T2DM and established CV disease and/or chronic kidney disease.

Heart rate variability biofeedback (HRVB) can reduce negative affect, craving, and substance use among individuals in early recovery from substance use disorder (SUD).

A mother’s death during or after pregnancy increases the risk for the infant’s death or hospitalization, according to a study.

Cardiac performance in patients with HF can be determined with measurement of the time for peak oxygen uptake to decrease by more than 12.5%.

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

A higher proportion of adolescents who tested positive for COVID-19 reported ongoing symptoms compared with those who tested negative or never tested.

Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Patients with various combinations of CKM comorbidities who receive GLP-1RAs have decreased risk for HF hospitalization and CV death.